leisure time -WSS

leisure time

author：comprehensive 2025-08-11 08:01:00 - browse：38647

How do cancer drugs work? What makes biotech stocks go up? And why are venture capitalists so optimistic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe. We also discuss the latest news in the life sciences, including the future of Alzheimer’s disease treatment, a multibillion-dollar deal, and the return of the biotech mega-round.

For more on what we cover, here’s STAT’s coverage of the European Society for Medical Oncology meeting; here’s more on Roivant Sciences; here’s the latest on biotech venture capital; here’s more on the latest Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Insmed lung disease drug hits target in key Phase 3 trial

Wikipedia

WSS

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Lab trade group sues FDA to halt regulation of lab

Life science postdocs should get big pay hike, NIH panel says

Physician assistants need a new name. Here's what it should be

In shift, Texas to cover initial consult for Afghan baby's gene therapy

focus

leisure time

entertainment

Virginia high school admissions case could be legal follow

Adam's Biotech Scorecard: Do Sarepta's exon

Walensky prepares to leave CDC — and Congress — behind

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Stories you might have missed in 2023: health, science, medicine

Activists slam private health insurers over coverage restrictions

Gene therapy denied for Afghan refugee whose father aided U.S.

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

focus

Health insurers say they are turning to AI to cut costs, improve care

Arena BioWorks launches in Cambridge to speed drug discovery

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

A preacher's new calling: Diversifying neuroscience research

First Opinion Podcast: What happens when kids become caregivers?

Wikipedia

Wikipedia

focus

focus